Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -3.28% | -10.66% | -418.02% |
| Total Depreciation and Amortization | -- | -- | -52.63% | -81.93% | -69.64% |
| Total Amortization of Deferred Charges | -- | -- | 28,816.67% | -- | -- |
| Total Other Non-Cash Items | -- | -- | -42.88% | -37.87% | 2,099.72% |
| Change in Net Operating Assets | -- | -- | -52.24% | 2,125.20% | 6,617.39% |
| Cash from Operations | -- | -- | -47.54% | -34.39% | -112.55% |
| Capital Expenditure | -- | -- | 65.96% | 65.96% | -93.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 77.45% |
| Cash from Investing | -- | -- | -478.98% | -311.84% | -46.73% |
| Total Debt Issued | -- | -- | 6,306.44% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -90.57% | -83.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 136.39% | 134.51% | 42.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 135.24% | 90.84% | -221.15% |
